Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Beam Therapeutics Inc (NASDAQ: BEAM) was $16.76 for the day, down -2.27% from the previous closing price of $17.15. In other words, the price has decreased by -$2.27 from its previous closing price. On the day, 1.5 million shares were traded. BEAM stock price reached its highest trading level at $17.3305 during the session, while it also had its lowest trading level at $16.63.
Ratios:
Our analysis of BEAM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 01 ’25 when Bellon Christine sold 5,674 shares for $18.35 per share. The transaction valued at 104,122 led to the insider holds 117,294 shares of the business.
Evans John M. sold 30,663 shares of BEAM for $562,684 on Apr 01 ’25. The CEO now owns 986,249 shares after completing the transaction at $18.35 per share. On Apr 01 ’25, another insider, Ciaramella Giuseppe, who serves as the President of the company, sold 7,434 shares for $18.35 each. As a result, the insider received 136,418 and left with 190,216 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1685335296 and an Enterprise Value of 572045888. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.51 while its Price-to-Book (P/B) ratio in mrq is 1.50. Its current Enterprise Value per Revenue stands at 8.998 whereas that against EBITDA is -1.4.
Stock Price History:
The Beta on a monthly basis for BEAM is 2.09, which has changed by -0.30108422 over the last 52 weeks, in comparison to a change of 0.111126065 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is -5.26%, while the 200-Day Moving Average is calculated to be -28.01%.
Shares Statistics:
BEAM traded an average of 2.24M shares per day over the past three months and 1774370 shares per day over the past ten days. A total of 100.56M shares are outstanding, with a floating share count of 89.62M. Insiders hold about 10.88% of the company’s shares, while institutions hold 88.04% stake in the company. Shares short for BEAM as of 1748563200 were 21159376 with a Short Ratio of 9.44, compared to 1745971200 on 19260565. Therefore, it implies a Short% of Shares Outstanding of 21159376 and a Short% of Float of 23.669999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
